Impact of disease modifying therapy on fatigue among multiple sclerosis patients

被引：0
作者：
Elkhooly, Mahmoud [1 ,2 ]
Raghib, Muhammad [1 ]
Lazar, Emily [1 ]
Lazar, Adam [1 ]
Liaquat, Zaima [1 ]
Martinez, Carla [1 ]
Rube, Jacob [1 ]
Bernitsas, Evanthia [1 ]
机构：
[1] Wayne State Univ, Neurol, Detroit, MI USA
[2] Minia Univ, Neurol & Psychiat, Al Minya, Egypt
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1620/2035
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [21] Time to relapse among propensity score matched patients receiving disease modifying therapy for multiple sclerosis
    Johnson, B. H.
    Bonafede, M. M.
    Watson, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 202 - 203
  • [22] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee
    Stephenson, Judith J.
    Kamat, Siddhesh
    ADVANCES IN THERAPY, 2011, 28 (01) : 51 - 61
  • [23] Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis
    Hiangkiat Tan
    Qian Cai
    Sonalee Agarwal
    Judith J. Stephenson
    Siddhesh Kamat
    Advances in Therapy, 2011, 28 : 51 - 61
  • [24] Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
    Molazadeh, Negar
    Sahraian, Mohammad Ali
    Ghajarzadeh, Mahsa
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 89 - 93
  • [25] Variables affecting disease modifying therapy adherence and impact of adherence on multiple sclerosis patients (Egyptian experience)
    Abdelsalam, A.
    Elkabany, R.
    Alahmar, I.
    Elkholy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 802 - 803
  • [26] No association between disease modifying treatment and fatigue in multiple sclerosis
    Broch, Line
    Flemmen, Heidi Oyen
    Simonsen, Cecilia Smith
    Berg-Hansen, Pal
    Ormstad, Heidi
    Brunborg, Cathrine
    Celius, Elisabeth Gulowsen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [27] Comorbid anxiety, depression, and fatigue symptoms by disease modifying therapy: a national multiple sclerosis cohort
    Maldonado, D. Pimentel
    Hemond, C.
    Eusebio, J.
    Umeton, R.
    Morales, I. Berrios
    Mowry, E.
    Ionete, C.
    Fitzgerald, K.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 332 - 332
  • [28] Disease modifying therapy in the aging multiple sclerosis patient
    Corboy, J. R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 83 - 83
  • [29] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
    Longbrake, Erin E.
    Parks, Becky J.
    Cross, Anne H.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
  • [30] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
12345